Edgewise Therapeutics Inc. Common Stock vs Lululemon Athletica Inc — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.11 (market cap $4.02B), while Lululemon Athletica Inc trades at $93.89 (market cap $10.42B). The key difference: Lululemon Athletica Inc is far larger — about 2.6× Edgewise Therapeutics Inc. Common Stock's market cap, and Edgewise Therapeutics Inc. Common Stock is trading nearer its 52-week high, Lululemon Athletica Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Lululemon Athletica Inc for 106 Days on average.
| EWTX | LULU | |
|---|---|---|
Market Cap | $4.02B | $10.42B |
Volume | 1,446,128 | 2,574,419 |
Sector | Health | Consumer Cyclical |
52-Week High | $48.35 | $215.88 |
52-Week Low | $14.89 | $91.88 |
Typical Hold Time | 0 Days | 106 Days |
Enterprise Value | $3.56B | $11.17B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Lululemon stock trades at $94.34, near its 52-week low, reflecting a 54% decline year-to-date amid growth concerns and securities fraud investigations. The technical picture is bearish, with the stock below key moving averages. Fundamentally, the company maintains strong profitability with a 56.11% gross margin and 12.78% net margin, but revenue growth has slowed, and Q3 2026 earnings are pending. Analyst consensus is mixed, with a Hold rating predominant and a $97.67 price target.
The outlook is cautious due to competitive pressures, governance scrutiny, and potential legal liabilities. While valuation metrics like a P/E of 7.76 appear attractive, near-term risks from weakening fundamentals and negative sentiment may limit upside. Recovery hinges on reversing revenue trends and resolving legal overhangs, making the stock speculative for now.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →Lululemon Athletica Inc. designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls. Lululemon offers pants, shorts, tops, and jackets for both leisure and athletic activities such as yoga and running. The company also sells fitness accessories, such as bags, yoga mats, and equipment. Lululemon sells its products through more than 600 company-owned stores in 18 countries, e-commerce, outlets, and wholesale accounts. The company was founded in 1998 and is based in Vancouver, Canada.
Read more on LULU →